TAZIDIME IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tazidime In Plastic Container, and when can generic versions of Tazidime In Plastic Container launch?
Tazidime In Plastic Container is a drug marketed by Lilly and is included in one NDA.
The generic ingredient in TAZIDIME IN PLASTIC CONTAINER is ceftazidime. There are seventeen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the ceftazidime profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tazidime In Plastic Container
A generic version of TAZIDIME IN PLASTIC CONTAINER was approved as ceftazidime by ACS DOBFAR on November 20th, 1985.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TAZIDIME IN PLASTIC CONTAINER?
- What are the global sales for TAZIDIME IN PLASTIC CONTAINER?
- What is Average Wholesale Price for TAZIDIME IN PLASTIC CONTAINER?
Summary for TAZIDIME IN PLASTIC CONTAINER
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 42 |
DailyMed Link: | TAZIDIME IN PLASTIC CONTAINER at DailyMed |
US Patents and Regulatory Information for TAZIDIME IN PLASTIC CONTAINER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lilly | TAZIDIME IN PLASTIC CONTAINER | ceftazidime | INJECTABLE;INJECTION | 062739-001 | Jul 10, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Lilly | TAZIDIME IN PLASTIC CONTAINER | ceftazidime | INJECTABLE;INJECTION | 062739-002 | Jul 10, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |